16?-<wbr/>hydroxy Estrone

16?-hydroxy Estrone

CAT N°: 15208
Price:

From 182.00 154.70

The naturally-occurring estrogens are estrone (E1, Item No. 10006485), estradiol (E2, Item No. 10006315), and estriol (E3, Item No. 10006484).{9611} 16?-hydroxy Estrone (16?-OHE1) is a hydroxylated metabolite of E1 as well as an interconversion product with E2.{24474,24473} E1 is 16?-hydroxylated by cytochrome P450 (CYP) isoforms, including CYP1A1, CYP3A5, CYP3A4, and CYP3A7, with CYP3A5 being breast-specific.{24483} 16?-OHE1 is sulphatized or glucuronidated before excretion.{24483} It is increased in rheumatoid arthritis and decreased by physical activity.{24474,24473} Unlike the parent estrogens and other hydroxylated metabolites of E1, 16?-OHE1 binds covalently and persistently activates estrogen receptors.{24475} In addition, this metabolite increases cell proliferation and does not suppress TNF-? secretion, whereas other estrogen metabolites are not pro-proliferative and have marked effects on TNF-? secretion.{24474,24483} The levels of 16?-OHE1 are increased in some forms of hormone therapy.{24472} Because hormone therapy increases breast cancer risk, 16?-OHE1 has been implicated as a risk factor for breast cancer, although supportive data remains elusive.{24476,24483,24472}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 3,16?-dihydroxy-estra-1,3,5(10)-trien-17-one
  • Correlated keywords
    • steroids endocrinology cancers arthritis autoimmune diseases receptors agonists hormones estrones estradiols estriols E1 E2 E3 E-1 E-2 E-3 Es hydroxylated OHE1 OHE-1 OHEs interconversion cytochromes P450 CYP450 isoforms CYP1A1 CYP3A5 CYP3A4 Cyp3A7 CYP3A5 breast sulphatized glucuronidated rheumatoid arthritis estrogens metabolites cell proliferation therapy therapies risk factors hydroxyestrone 16?-hydroxyestrone
  • Product Overview:
    The naturally-occurring estrogens are estrone (E1, Item No. 10006485), estradiol (E2, Item No. 10006315), and estriol (E3, Item No. 10006484).{9611} 16?-hydroxy Estrone (16?-OHE1) is a hydroxylated metabolite of E1 as well as an interconversion product with E2.{24474,24473} E1 is 16?-hydroxylated by cytochrome P450 (CYP) isoforms, including CYP1A1, CYP3A5, CYP3A4, and CYP3A7, with CYP3A5 being breast-specific.{24483} 16?-OHE1 is sulphatized or glucuronidated before excretion.{24483} It is increased in rheumatoid arthritis and decreased by physical activity.{24474,24473} Unlike the parent estrogens and other hydroxylated metabolites of E1, 16?-OHE1 binds covalently and persistently activates estrogen receptors.{24475} In addition, this metabolite increases cell proliferation and does not suppress TNF-? secretion, whereas other estrogen metabolites are not pro-proliferative and have marked effects on TNF-? secretion.{24474,24483} The levels of 16?-OHE1 are increased in some forms of hormone therapy.{24472} Because hormone therapy increases breast cancer risk, 16?-OHE1 has been implicated as a risk factor for breast cancer, although supportive data remains elusive.{24476,24483,24472}

We also advise you